Key facts
- This page summarizes Timothy R. Wright's Form 4 filing for AGENUS INC (AGEN).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 04 Oct 2023, 17:12.
Timothy R. Wright - 02 Oct 2023 Form 4 Insider Report for AGENUS INC (AGEN)
- Reporting relationship
- Director
- Issuer ticker
- AGEN
- Reported as of
- 02 Oct 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Oct 2023, 17:12:06 UTC
- Prior SEC filing
- 06 Jul 2023
- Next SEC filing
- 12 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/Christine Klaskin as Attorney-in-Fact for Timothy R. Wright
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Timothy R. Wright filed Form 4 for AGENUS INC (AGEN) on 04 Oct 2023.
Change
- Previous filing in this sequence was filed on 06 Jul 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AGEN
transaction
Derivative
Deferred Stock Units
Award
- Transaction value
- Shares
- +6,586
- Change %
- +4.1%
- Price
- Shares after
- 167,398
- Date
- 02 Oct 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 6,586
- Exercise price
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Deferred Stock Units convert to shares of Common Stock on a 1 for 1 basis.
Footnote F2
Acquired under the Agenus Inc. Amended and Restated Directors' Deferred Compensation Plan, as amended (the "Plan"). Deferred Stock Units represent an equal amount of the Company's common stock to be distributed under the terms of the Plan, typically once the director ceases to serve as a director of the Company.
Footnote F3
$1.42 per Deferred Stock Unit acquired on October 2, 2023. The price of each Deferred Stock Unit acquired on October 2, 2023 is the average of the closing price for the Company's common stock for all trading days during the calendar quarter immediately preceding the date such Deferred Stock Unit was acquired pursuant to the Plan. This amount also includes a downward adjustment of 27.45 Deferred Stock Units in respect of the grant dated July 3, 2023, as the average closing price used for such calculation incorrectly reflected a stock split and was increased on October 2, 2023 to $1.61 per Deferred Stock Unit.